MICHAEL PATRICK MILLER - 01 Jul 2022 Form 4 Insider Report for BioXcel Therapeutics, Inc. (BTAI)

Role
Director
Signature
/s/ Richard Steinhart, as Attorney-in-Fact for Michael Patrick Miller
Issuer symbol
BTAI
Transactions as of
01 Jul 2022
Net transactions value
$0
Form type
4
Filing time
05 Jul 2022, 21:04:11 UTC
Previous filing
16 Jun 2022
Next filing
10 Aug 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BTAI Stock Option (Right to Buy) Award $0 +30,000 $0.000000 30,000 01 Jul 2022 Common Stock 30,000 $14.27 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable in three substantially equal annual installments following the date of grant, subject to the Reporting Person's continued service through each vesting date.